Jisi Yingda
Shanghai
About Jisi Yingda
Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $14.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2021)
- Website: jsinnopharm.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/jisi-yingda-106129 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.